Clinical Trial Update: A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether semaglutide versus placebo affects diabetic retinopathy in people with Type 2 diabetes; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: ACTIVE_NOT_RECRUITING